首页> Nature medicine> A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial.

A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial.

导出 OA

翻译打印收藏纠错

第一作者： Marina,Baretti

第一单位： The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

作者： Marina,Baretti ^[1] ; Allison M,Kirk ^[2] ; Brian H,Ladle ^[1] ; Zeal,Kamdar ^[1] ; Kayla J,Bendinelli ^[1] ; Won Jin,Ho ^[1] ; Samir,Adhikari ^[2] ; Nicholas A,Clark ^[2] ; Balaji,Sundararaman ^[2] ; Hao,Wang ^[1] ; Heng-Chung,Kung ^[1] ; Jeric,Hernandez ^[1] ; Hanfei,Qi ^[1] ; Sarah M,Shin ^[1] ; Alexei,Hernandez ^[1] ; Mari,Nakazawa ^[1] ; Stefan A,Schattgen ^[2] ; Jeremy Chase,Crawford ^[2] ; Mark,Furth ^[3] ; Robert A,Anders ^[1] ; Chris,Thoburn ^[1] ; Neeha,Zaidi ^[1] ; Amanda L,Huff ^[1] ; Julie,Nauroth ^[1] ; Elizabeth,Jaffee ^[1] ; Mikhail V,Pogorelyy ^[2] ; Paul G,Thomas ^[4] ; Mark,Yarchoan ^[5]

作者单位： The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. ^[1] Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN, USA. ^[2] Fibrolamellar Cancer Foundation, Greenwich, CT, USA. ^[3] Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN, USA. paul.thomas@stjude.org. ^[4] The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. mark.yarchoan@jhmi.edu. ^[5]